Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Work In Process (2016 - 2025)

InspireMD filings provide 14 years of Work In Process readings, the most recent being $930000.0 for Q4 2025.

  • On a quarterly basis, Work In Process rose 45.77% to $930000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $930000.0, a 45.77% increase, with the full-year FY2025 number at $930000.0, up 45.77% from a year prior.
  • Work In Process hit $930000.0 in Q4 2025 for InspireMD, up from $733000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $930000.0 in Q4 2025 to a low of $223000.0 in Q1 2021.
  • Median Work In Process over the past 5 years was $537000.0 (2024), compared with a mean of $556315.8.
  • Biggest five-year swings in Work In Process: dropped 20.64% in 2021 and later skyrocketed 122.87% in 2022.
  • InspireMD's Work In Process stood at $436000.0 in 2021, then rose by 16.97% to $510000.0 in 2022, then rose by 10.2% to $562000.0 in 2023, then rose by 13.52% to $638000.0 in 2024, then surged by 45.77% to $930000.0 in 2025.
  • The last three reported values for Work In Process were $930000.0 (Q4 2025), $733000.0 (Q3 2025), and $865000.0 (Q2 2025) per Business Quant data.